Big Brother
7 years ago
Might be getting ready to go, could be nothing, just watching right now.
Market cap is currently sitting at around $9M, Swiftlet Eco Park has been valued at $200M US, so this could potentially be one of those Asian tickers that runs big($10+ pps)......or.....could be illiquid and rarely get any buying action at all, hard to say at this point.
Big Brother
8 years ago
Unless I'm mistaken, looking back at the historical record, it appears yesterday's 2,000 shares was the first ever day of trading for this ticker.
IMO it seems like they are willing to let a few shares go early before officially announcing a Swiftlet Eco Park merger or acquisition. The 8K only mentioned a change of control but Swiftlet Eco Park has wanted to go public on a US exchange for a couple of years, so that clearly must be whats happening here.
http://www.dealstreetasia.com/stories/swiftlet-eco-park-bhd-plans-30m-ipo-nyse-3q-3394/
http://www.thestar.com.my/news/nation/2016/09/04/swiftlet-eco-park-group-looks-to-us-listing/
Question is whats a good price for this and what kind of demand will their be for a Malaysian OTCQB reverse merger company..?? More then likely it will be quite illiquid, and probably significantly undervalued as well.
Big Brother
8 years ago
Change of control of this shell company.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11667998
Mr Tan Chee Hong, a Malaysian, aged 44, is an Executive Director of Swiftlet Eco Park Holdings Sdn Bhd. He is also the Group Executive Director and Chief Executive Officer for Swiftlet Eco Park Berhad, RBN Global Berhad, Royal Bird’s Nest Sdn Bhd, RBN Aesthetic Wellness Sdn Bhd, the members of Swiftlet Eco Park Group of Companies. A graduate from University of Science Malaysia with a Bachelor of Science degree in Business Management, he has 11 years of experience with one of the leading Japanese conglomerate company, for corporate and strategic planning, regional business development in Asia Pacific and held key executive positions in managing cross border business and had served in various overseas portfolios in Tokyo, Shanghai and Singapore. With vast experience in international trade for industrial business of specialty chemicals, electronics, semiconductor, engineering plastics, healthcare medical and biotechnology, he has forged key technical alliance with foreign biotechnology company to manage the Malaysian research and development operations for pharmaceuticals industry. He was the Managing Director of Lexxus Biotech (M) Sdn Bhd, the subsidiary company of DTH Corporation, being one of the first bioinformatics company in the country, frontier in project management with local research & development institutions. In addition, he obtained his MBA from University of Portsmouth, UK in 1998 and as the Group Executive Director and Chief Executive Officer; he leads and manages the global business growth for the group.